Marginalia
Consideration before wrapping up the kits as gifts: privacy concerns. 23andMe raised eyebrows earlier this year when pharmaceutical company GlaxoSmithKline announced that it had invested $300 million in 23andMe as part of a collaboration aimed at developing new medications using 23andMe’s data. The companies plan to share in the proceeds from any new medications or treatments that come out of the partnership.